Hopeful but not cure: Patients with a V600 BRAF mutation, approximately 40-60% of melanoma patients! and with metastatic/advanced disease may benefit from Debrafenib. However it is not a cure and it tend to prolong disease free survival rather and is typically used in combination with other treatments for optimal outcomes
Answered 5/31/2015
2.8k views
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question